Most Liquid Obamacare Repeal Companies

Cash And Equivalents
Cash And EquivalentsEfficiencyMarket RiskExp Return
1UNH UnitedHealth Group Incorporated
27.91 B
 0.01 
 1.46 
 0.01 
2ABT Abbott Laboratories
9.88 B
 0.14 
 1.08 
 0.15 
3MCK McKesson
4.68 B
(0.11)
 2.24 
(0.25)
4ISRG Intuitive Surgical
4.32 B
 0.13 
 1.78 
 0.24 
5CAH Cardinal Health
4.04 B
 0.18 
 1.16 
 0.20 
6ZTS Zoetis Inc
3.58 B
 0.00 
 1.41 
(0.01)
7HOLX Hologic
2.39 B
 0.03 
 1.09 
 0.03 
8SYK Stryker
1.84 B
 0.09 
 1.16 
 0.10 
9BAX Baxter International
1.72 B
 0.01 
 1.88 
 0.03 
10MDT Medtronic PLC
1.54 B
 0.21 
 1.00 
 0.21 
11BDX Becton Dickinson and
1.42 B
 0.01 
 1.00 
 0.01 
12ALGN Align Technology
1.09 B
 0.00 
 2.49 
 0.00 
13BSX Boston Scientific Corp
928 M
 0.19 
 0.96 
 0.18 
14HCA HCA Holdings
908 M
 0.02 
 1.65 
 0.04 
15WST West Pharmaceutical Services
894.3 M
 0.05 
 2.71 
 0.14 
16NBIX Neurocrine Biosciences
799.4 M
(0.10)
 2.92 
(0.30)
17EW Edwards Lifesciences Corp
769 M
 0.09 
 1.70 
 0.15 
18PODD Insulet
708.6 M
 0.14 
 2.38 
 0.34 
19SNN Smith Nephew SNATS
516 M
 0.00 
 1.45 
 0.00 
20IRWD Ironwood Pharmaceuticals
504.36 M
(0.13)
 5.54 
(0.70)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes. Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).